Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Female gender as a conditioning factor of benzodiazepine unsafety during the COVID-19 pandemic.

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: CPS-003
  • By: ALBERTO ARMAS, Daida (Universidad de La Laguna (ULL), Spain)
  • Co-author(s): Dr Daida Alberto Armas, Community Pharmacy/ Toxicology Department (Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Spain)
    Prof.Dr. Carmen Rubio Armendáriz, Toxicology Department (Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Spain)
    Prof.Dr. Arturo Hardisson de la Torre, Toxicology Department (Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Spain)
  • Abstract:

    Background information:
    The female gender suffers a higher prevalence of pathologies such as depression and anxiety doubling the incidence compared to the male gender according to the 2020 report of the Spanish Society of Public Health and Health Administration (SESPAS). Benzodiazepines (BZD) used to treat these pathologies are not free of risks..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses